Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis
ConclusionsIn patients with heart failure, sacubitril/valsartan was demonstrated to be superior to SGLT2 inhibitors in the treatment effect for the composite of heart failure hospitalisation and cardiovascular death, cardiovascular death, and long-term blood pressure.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Diovan | Drugs & Pharmacology | Enalapril | Heart | Heart Failure | SGLT2 Inhibitors | Sodium | Study